Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04517604 · ClinicalTrials.gov registry record · NA

Neuromodulation and Yoga for Mild Traumatic Brain Injury and Chronic Pain

A NA study of Chronic Pain and Mild Traumatic Brain Injury, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
19
Enrollment target
1
Study location

NCT04517604 is a NA study of Chronic Pain and Mild Traumatic Brain Injury that has completed, run by VA Office of Research and Development. The registered enrollment target is 19 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04517604, a NA study of Chronic Pain and Mild Traumatic Brain Injury, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
19 participants
Enrollment target
1
Study location

Study Summary

The objectives of this VA SPiRE application are to develop a combined neuromodulation and yoga (iTBS+yoga) intervention for Veterans with mild traumatic brain injury (mTBI) and chronic pain, assess the intervention's feasibility and acceptability, and to gather preliminary clinical outcome data on quality of life, function and pain that will guide future studies. This SPiRE project will directly benefit Veterans and VA Services by developing a new, non-pharmacological neurorehabilitation treatment for Veterans with mTBI and chronic pain in need of non-opioid treatment options. Neuromodulation is now offered at 30 VA hospitals and yoga is among the complementary and integrative health programs being rolled out as a part of VAs Whole Health implementation efforts. Thus, should iTBS+yoga ultimately prove to be efficacious, VA facilities will be well-poised to offer this treatment. A novel, activity-based, non-pharmacological treatment for Veterans with mTBI and chronic pain is of great need given the high prevalence of chronic pain.

Interventions

  • DEVICE Magventure MagProx100 with MagOption

Study Locations (1)

Illinois

  • Edward Hines Jr. VA Hospital, Hines, IL - Hines

Trial Details

FieldValue
Enrollment Target 19 participants
Start Date 2021-06-01
Est. Completion 2023-08-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT04517604

The ClinicalTrials.gov registry entry for NCT04517604 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (98% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 1 intervention - of which Magventure MagProx100 with MagOption is the first listed.

NCT04517604 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04517604 about?

NCT04517604 is a clinical study titled "Neuromodulation and Yoga for Mild Traumatic Brain Injury and Chronic Pain". The objectives of this VA SPiRE application are to develop a combined neuromodulation and yoga (iTBS+yoga) intervention for Veterans with mild traumatic brain injury (mTBI) and chronic pain, assess the intervention's feasibility and acceptability, and to gather preliminary clinical outcome data on q...

What is the current status of trial NCT04517604?

This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2021-06-01. Estimated completion is 2023-08-31.

What conditions does trial NCT04517604 study?

This clinical trial studies the following conditions: Chronic Pain, Mild Traumatic Brain Injury.

What interventions are being tested in trial NCT04517604?

The interventions under investigation include: Magventure MagProx100 with MagOption (DEVICE).

Who is sponsoring clinical trial NCT04517604?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04517604 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.